Improving the quality of life

for millions of patients

View latest announcements

Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development.

OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.

All News

  • 08 January 2019

    The Times: An interview with Neil Mahapatra

    SOURCE: THE TIMES MAGAZINE

  • 09 August 2018

    High life: the start-up hoping to unlock the secrets of medical cannabis

    SOURCE: EVENING STANDARD

  • 28 June 2018

    OXFORD CANNABINOID TECHNOLOGIES GOES GLOBAL AS IT ANNOUNCES CLOSE OF SERIES A FUNDRAISING ROUND AND MANAGEMENT TEAM LINE-UP

    SOURCE: OCT PRESS RELEASE